Wang X, Yang Z, Xue B, Shi H
In contrast, SGLT2 inhibitors and GLP-1 receptor agonists are newer standard therapies that reduce glycemia while conferring proven cardiovascular and renal benefits, making them preferred agents for improving outcomes beyond HbA1c reduction alone
studies show users who stop therapy regain 50% of lost weight within a year, while those who maintain treatment preserve most gains
Choosing an area with more subcutaneous fat, like the abdomen or thigh, and letting the medication reach room temperature can further reduce any discomfort
Skin whitening is classified as a drug claim (altering the structure or function of the body), not a cosmetic claimproducts marketed for this purpose require FDA approval as a drug, which glutathione does not have